B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

D. L. Petersen; T. Krejsgaard; J. Berthelsen; S. Fredholm; A. Willerslev-Olsen; N. A. Sibbesen; C. M. Bonefeld; M. H. Andersen; C. Francavilla; J. V. Olsen; T. Hu; M. Zhang; M. A. Wasik; C. Geisler; A. Woetmann; N. Odum

doi:10.1038/leu.2014.192

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

D. L. Petersen
, T. Krejsgaard
, J. Berthelsen
, S. Fredholm
, A. Willerslev-Olsen
, N. A. Sibbesen
, C. M. Bonefeld
, M. H. Andersen
, C. Francavilla
, J. V. Olsen
, T. Hu
, M. Zhang
, M. A. Wasik
, C. Geisler
, A. Woetmann
, N. Odum

Research output: Contribution to journal › Letter › peer-review

36 Scopus citations

Original language	English
Pages (from-to)	2109-2112
Number of pages	4
Journal	Leukemia
Volume	28
Issue number	10
DOIs	https://doi.org/10.1038/leu.2014.192
State	Published - Oct 1 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Animals
Cell Line, Tumor
Cell Proliferation
Dasatinib
Gene Expression Regulation, Neoplastic
Humans
Lymphoma, T-Cell, Cutaneous/genetics
Mice
Neoplasm Transplantation
Neoplasms/metabolism
Phosphorylation
Pyrimidines/administration & dosage
Thiazoles/administration & dosage
src-Family Kinases/metabolism

Access to Document

10.1038/leu.2014.192

Cite this

Petersen, D. L., Krejsgaard, T., Berthelsen, J., Fredholm, S., Willerslev-Olsen, A., Sibbesen, N. A., Bonefeld, C. M., Andersen, M. H., Francavilla, C., Olsen, J. V., Hu, T., Zhang, M., Wasik, M. A., Geisler, C., Woetmann, A., & Odum, N. (2014). B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL). Leukemia, 28(10), 2109-2112. https://doi.org/10.1038/leu.2014.192

@article{22b1cf93dc4e4266950278e91897ac96,

title = "B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)",

keywords = "Animals, Cell Line, Tumor, Cell Proliferation, Dasatinib, Gene Expression Regulation, Neoplastic, Humans, Lymphoma, T-Cell, Cutaneous/genetics, Mice, Neoplasm Transplantation, Neoplasms/metabolism, Phosphorylation, Pyrimidines/administration \& dosage, Thiazoles/administration \& dosage, src-Family Kinases/metabolism",

author = "Petersen, \{D. L.\} and T. Krejsgaard and J. Berthelsen and S. Fredholm and A. Willerslev-Olsen and Sibbesen, \{N. A.\} and Bonefeld, \{C. M.\} and Andersen, \{M. H.\} and C. Francavilla and Olsen, \{J. V.\} and T. Hu and M. Zhang and Wasik, \{M. A.\} and C. Geisler and A. Woetmann and N. Odum",

year = "2014",

month = oct,

day = "1",

doi = "10.1038/leu.2014.192",

language = "English",

volume = "28",

pages = "2109--2112",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "10",

}

Petersen, DL, Krejsgaard, T, Berthelsen, J, Fredholm, S, Willerslev-Olsen, A, Sibbesen, NA, Bonefeld, CM, Andersen, MH, Francavilla, C, Olsen, JV, Hu, T, Zhang, M, Wasik, MA, Geisler, C, Woetmann, A & Odum, N 2014, 'B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)', Leukemia, vol. 28, no. 10, pp. 2109-2112. https://doi.org/10.1038/leu.2014.192

TY - JOUR

T1 - B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

AU - Petersen, D. L.

AU - Krejsgaard, T.

AU - Berthelsen, J.

AU - Fredholm, S.

AU - Willerslev-Olsen, A.

AU - Sibbesen, N. A.

AU - Bonefeld, C. M.

AU - Andersen, M. H.

AU - Francavilla, C.

AU - Olsen, J. V.

AU - Hu, T.

AU - Zhang, M.

AU - Wasik, M. A.

AU - Geisler, C.

AU - Woetmann, A.

AU - Odum, N.

PY - 2014/10/1

Y1 - 2014/10/1

KW - Animals

KW - Cell Line, Tumor

KW - Cell Proliferation

KW - Dasatinib

KW - Gene Expression Regulation, Neoplastic

KW - Humans

KW - Lymphoma, T-Cell, Cutaneous/genetics

KW - Mice

KW - Neoplasm Transplantation

KW - Neoplasms/metabolism

KW - Phosphorylation

KW - Pyrimidines/administration & dosage

KW - Thiazoles/administration & dosage

KW - src-Family Kinases/metabolism

UR - https://www.scopus.com/pages/publications/84921823055

U2 - 10.1038/leu.2014.192

DO - 10.1038/leu.2014.192

M3 - Letter

C2 - 24919804

AN - SCOPUS:84921823055

SN - 0887-6924

VL - 28

SP - 2109

EP - 2112

JO - Leukemia

JF - Leukemia

IS - 10

ER -

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this